NASDAQ:PLUR Pluri (PLUR) Stock Price, News & Analysis $1.08 0.00 (0.00%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$1.02 -0.06 (-5.09%) As of 09/18/2026 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Pluri Stock (NASDAQ:PLUR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pluri alerts:Sign Up Key Stats Today's Range$1.02▼$1.1650-Day Range$1.08▼$1.9552-Week Range$1.02▼$4.87Volume23,832 shsAverage Volume28,802 shsMarket Capitalization$13.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Pluri Ltd. is an Israel-based biotechnology company that develops cell-based products using its proprietary three-dimensional cell expansion technology. The platform is designed to produce large quantities of potentially therapeutic and commercial cells while maintaining consistent quality and scalability. The company’s research and development activities have included placenta-derived, off-the-shelf cell therapies, historically marketed under the PLX platform. These programs have targeted areas such as regenerative medicine, inflammation, cancer, orthopedic conditions and other medical needs. Pluri has also expanded its technology applications into areas including cell-based food and other non-pharmaceutical products. Founded as Pluristem Therapeutics, the company adopted the name Pluri Ltd. in 2022. It is headquartered in Haifa, Israel, and develops its products for potential use in global healthcare and biotechnology markets through research programs and strategic collaborations. Yaky Yanay serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Pluri Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScorePLUR MarketRank™: Pluri scored higher than 5% of companies evaluated by MarketBeat, and ranked 873rd out of 895 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPluri has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePluri has only been the subject of 1 research reports in the past 90 days.Read more about Pluri's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Pluri is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pluri is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Pluri's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.42% of the float of Pluri has been sold short.Short Interest Ratio / Days to CoverPluri has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pluri has recently increased by 70.49%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPluri does not currently pay a dividend.Dividend GrowthPluri does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Pluri this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Pluri to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pluri insiders have not sold or bought any company stock.Percentage Held by Insiders43.16% of the stock of Pluri is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.59% of the stock of Pluri is held by institutions.Read more about Pluri's insider trading history. Receive PLUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PLUR Stock News HeadlinesPluri (PLUR) to Release Quarterly Earnings on WednesdaySeptember 16, 2026 | americanbankingnews.comPluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026September 10, 2026 | marketscreener.comMHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)Pluri Announces August 2026 Equity Financing TransactionAugust 28, 2026 | tipranks.comPluri prices $3.3 million offeringAugust 27, 2026 | seekingalpha.comPluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional InvestorAugust 27, 2026 | globenewswire.comPluri Subsidiary Acquires Fishway to Expand Cultivated SeafoodAugust 17, 2026 | tipranks.comPluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic InvestmentAugust 17, 2026 | globenewswire.comSee More Headlines PLUR Stock Analysis - Frequently Asked Questions How have PLUR shares performed this year? Pluri's stock was trading at $2.99 at the start of the year. Since then, PLUR shares have decreased by 63.9% and is now trading at $1.08. How were Pluri's earnings last quarter? Pluri Inc. (NASDAQ:PLUR) issued its quarterly earnings data on Thursday, September, 10th. The company reported ($0.54) EPS for the quarter, topping analysts' consensus estimates of ($0.66) by $0.12. The firm had revenue of $0.34 million for the quarter, compared to analysts' expectations of $0.66 million. When did Pluri's stock split? Shares of Pluri reverse split before market open on Monday, April 1st 2024.The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Pluri? Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pluri own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pluri investors own include Digital Turbine (APPS), Lightning eMotors (ZEV), Archer Aviation (ACHR), ChargePoint (CHPT) and Canoo (GOEV). Company Calendar Last Earnings9/10/2026Today9/21/2026Next Earnings (Estimated)9/23/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 PLUR's financial health is in the Red zone, according to TradeSmith. PLUR has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:PLUR CIK1158780 Webpluri-biotech.com Phone+972747107171Fax972-74-710-8787Employees113Year Founded2001Profitability EPS (Trailing Twelve Months)($2.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.82 million Net Margins-2,344.59% Pretax Margin-2,499.41% Return on EquityN/A Return on Assets-82.71% Debt Debt-to-Equity RatioN/A Current Ratio0.27 Quick Ratio0.27 Sales & Book Value Annual Sales$1.02 million Price / Sales13.08 Cash FlowN/A Price / Cash FlowN/A Book Value($1.62) per share Price / Book-0.67Miscellaneous Outstanding Shares12,350,000Free Float7,017,000Market Cap$13.34 million OptionableNo Data Beta0.68 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:PLUR) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pluri With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
